Agnitio Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AGNITIO, and what generic and branded alternatives to AGNITIO drugs are available?
AGNITIO has four approved drugs.
Drugs and US Patents for Agnitio
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Agnitio | TRIAMTERENE | triamterene | CAPSULE;ORAL | 211581-002 | Aug 19, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Agnitio | ATORVASTATIN CALCIUM | atorvastatin calcium | TABLET;ORAL | 214969-001 | Sep 2, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Agnitio | ATORVASTATIN CALCIUM | atorvastatin calcium | TABLET;ORAL | 214969-004 | Sep 2, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.